Company Filing History:
Years Active: 2022
Title: Trevor Lawley: Innovator in Cancer Treatment
Introduction
Trevor Lawley is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, Lawley's work focuses on the use of bacterial compositions in therapeutic applications.
Latest Patents
Lawley's latest patents include a therapeutic bacterial composition and a bacterial biomarker. The therapeutic bacterial composition relates to bacterial compositions that are useful in the treatment of cancer. Specifically, these compositions can be utilized as a co-therapy alongside immune checkpoint therapy. Additionally, the invention encompasses methods for identifying subjects who are likely to respond to therapy with an immune checkpoint inhibitor by determining the abundance of bacteria in a biological sample from the subject. The bacterial biomarker patent shares similar themes, emphasizing the role of bacterial compositions in cancer treatment.
Career Highlights
Throughout his career, Trevor Lawley has worked with prominent companies such as Microbiotica GmbH and Genome Research Limited. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative cancer therapies.
Collaborations
Some of Lawley's notable coworkers include Matthew Robinson and Michael Romanos. Their collaboration has likely played a role in the success of his research endeavors.
Conclusion
Trevor Lawley is a distinguished inventor whose work in cancer treatment through bacterial compositions has the potential to revolutionize therapeutic approaches. His patents reflect a commitment to advancing medical science and improving patient outcomes.